MMED MiniMed Group, Inc. - Common Stock

NASDAQ · · Lihat di SEC EDGAR ↗
$19,95
Harga · Agu 19, 2026
Fundamental per Jun 29, 2026
Rentang 52M
$11–$21
91% of range
Peringkat Analis
BUY
18 analysts
Target Harga
$21
+4% upside
P/E (TTM)
-15.3
ROE
-9.3%
Margin Laba Bersih
-10.7%

MMED Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

Harga
$19.95
Kapitalisasi Pasar
$5.60B
P/E (TTM)
-15.3
EPS (TTM)
$-1.30
Pendapatan (TTM)
$3.10B
Imbal Hasil Dividen
—
ROE
-9.3%
D/E Utang/Ekuitas
—
Rentang 52M
$11 – $21

MMED Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

Pendapatan & Laba Bersih $3.10B
3-point trend, +25.6%
2024-04-26 → 2026-04-24
EPS $-1.30
3-point trend, -195.5%
2024-04-26 → 2026-04-24
Arus Kas Bebas $-420M
2026-04-24 → 2026-04-24
Margin -10.7%
2026-04-24 → 2026-04-24

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik
Tren 5 Tahun
MMED
Median Rekan
P/E (TTM)
-15.3
34.5
P/S (TTM)
1.8
3.0
P/B
1.6
3.0
Price / FCF (Harga / FCF)
-13.3
—

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik
Tren 5 Tahun
MMED
Median Rekan
Gross Margin (Margin Kotor)
54.2%
49.2%
Operating Margin (Margin Operasi)
-6.1%
—
Net Profit Margin (Margin Laba Bersih)
-10.7%
4.7%
ROA
-7.5%
2.6%
ROE
-9.3%
5.6%
ROIC
-8.8%
—

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik
Tren 5 Tahun
MMED
Median Rekan
Current Ratio (Rasio Lancar)
1.9
2.9
Quick Ratio (Rasio Cepat)
0.7
—

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik
Tren 5 Tahun
MMED
Median Rekan
Revenue YoY (Pendapatan YoY)
3-point trend, +25.6%
14.2%
—

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik
Tren 5 Tahun
MMED
Median Rekan
EPS (Diluted)
3-point trend, -195.5%
$-1.30
—

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik
Tren 5 Tahun
MMED
Median Rekan

MMED Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

BELI 18 analis
  • Beli Kuat 6 33,3%
  • Beli 10 55,6%
  • Tahan 2 11,1%
  • Jual 0 0,0%
  • Jual Kuat 0 0,0%

Target Harga 12 Bulan

12 analis · 2026-08-19
Target median $20.50 +2,8%
Target rata-rata $20.83 +4,5%

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

Kejutan Rata-rata
-0.57%
Laporan Berikutnya
Sep 01, 2026
Periode EPS Aktual EPS Estimasi Kejutan
31 Des. 2026 $-0.68 $-0.17 —
30 Juni 2026 $-0.68 $-0.17 -0.51%
31 Maret 2026 $-0.47 $0.16 -0.63%

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

Ticker Kapitalisasi Pasar P/E Pendapatan YoY Margin Bersih ROE Margin Kotor
MMED $3.71B -10.2 14.2% -10.7% -9.3% 54.2%
MDLN — -4200.0 11.5% 4.1% 21.6% 26.4%
SOLV $13.75B 8.9 0.86% 18.7% 35.8% 53.5%
COO $13.70B 37.4 5.1% 9.2% 4.6% 65.5%
ALGN $11.14B 27.6 0.90% 10.2% 10.3% 67.2%
LNTH $4.30B 19.5 0.50% 15.2% 20.7% 61.1%
MMSI $5.24B 41.4 11.8% 8.5% 8.4% 48.7%
ICUI $3.52B 4755.7 -6.3% 0.03% 0.03% 36.8%
HAE $2.45B 26.4 -2.0% 7.3% 11.8% 59.0%
QDEL $1.99B -1.8 -1.9% -41.4% -48.0% —
XRAY $2.28B -3.8 -3.0% -16.2% -36.4% 50.0%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

Laporan Laba Rugi 14
Data Laporan Laba Rugi Tahunan untuk MMED
Metrik Tren 20262025
Revenue 2-point trend, +14.3% $3.10B $2.71B
Cost of Revenue 2-point trend, +19.8% $1.42B $1.19B
Gross Profit 2-point trend, +9.9% $1.68B $1.53B
SG&A Expense 2-point trend, +9.5% $1.18B $1.08B
Operating Income 2-point trend, -30.1% $-190M $-146M
Other Non-op 2-point trend, +200.0% $1M $-1M
Pretax Income 2-point trend, -28.6% $-189M $-147M
Income Tax 2-point trend, +146.2% $128M $52M
Net Income 2-point trend, -56.3% $-333M $-213M
EPS (Basic) 2-point trend, -54.8% $-1.30 $-0.84
EPS (Diluted) 2-point trend, -54.8% $-1.30 $-0.84
Shares (Basic) 2-point trend, +1.5% 256,600,000 252,800,000
Shares (Diluted) 2-point trend, +1.5% 256,600,000 252,800,000
EBITDA $-34M ·
Neraca 24
Data Neraca Tahunan untuk MMED
Metrik Tren 20262025
Cash & Equivalents 2-point trend, +2609.1% $298M $11M
Receivables 2-point trend, -64.9% $200M $570M
Inventory 2-point trend, +9.6% $341M $311M
Other Current Assets 2-point trend, +12.5% $54M $48M
Current Assets 2-point trend, +43.6% $1.35B $939M
PP&E (Net) 2-point trend, +0.7% $711M $706M
PP&E (Gross) 2-point trend, +9.0% $1.49B $1.37B
Accum. Depreciation 2-point trend, +17.8% $781M $663M
Goodwill 2-point trend, +0.0% $2.26B $2.25B
Intangibles 2-point trend, -18.9% $107M $132M
Other Non-current Assets 2-point trend, -2.0% $147M $150M
Total Assets 2-point trend, +10.2% $4.63B $4.20B
Accounts Payable 2-point trend, -20.5% $163M $205M
Current Liabilities 2-point trend, -1.1% $702M $710M
Capital Leases 2-point trend, -19.6% $45M $56M
Other Non-current Liabilities 2-point trend, +95.7% $317M $162M
Total Liabilities 2-point trend, +17.0% $1.02B $871M
Common Stock 2-point trend, +3000000.00 $3M $0
Paid-in Capital 2-point trend, +3736000000.00 $3.74B $0
Retained Earnings 2-point trend, -116000000.00 $-116M $0
AOCI 2-point trend, -500.0% $-12M $3M
Stockholders' Equity 2-point trend, +8.4% $3.61B $3.33B
Liabilities + Equity 2-point trend, +10.2% $4.63B $4.20B
Shares Outstanding 2-point trend, +280819988.00 280,819,988 0
Arus Kas 12
Data Arus Kas Tahunan untuk MMED
Metrik Tren 20262025
D&A 2-point trend, +9.1% $156M $143M
Stock-based Comp 2-point trend, +12.2% $46M $41M
Deferred Tax 2-point trend, -2400.0% $-50M $-2M
Amort. of Intangibles 2-point trend, -10.3% $26M $29M
Other Non-cash $-16M ·
Operating Cash Flow 2-point trend, -240.7% $-197M $140M
CapEx 2-point trend, +15.5% $223M $193M
Investing Cash Flow 2-point trend, -20.7% $-233M $-193M
Financing Cash Flow 2-point trend, +7060.0% $716M $10M
Net Change in Cash 2-point trend, +767.4% $287M $-43M
Taxes Paid 2-point trend, +2000000.00 $2M $0
Free Cash Flow $-420M ·
Profitabilitas 8
Data Profitabilitas Tahunan untuk MMED
Metrik Tren 20262025
Gross Margin 54.2% ·
Operating Margin -6.1% ·
Net Margin -10.7% ·
Pretax Margin -6.1% ·
EBITDA Margin -1.1% ·
ROA -7.5% ·
ROE -9.3% ·
ROIC -8.8% ·
Likuiditas & Solvabilitas 2
Data Likuiditas & Solvabilitas Tahunan untuk MMED
Metrik Tren 20262025
Current Ratio 1.9 ·
Quick Ratio 0.7 ·
Efisiensi 3
Data Efisiensi Tahunan untuk MMED
Metrik Tren 20262025
Asset Turnover 0.7 ·
Inventory Turnover 4.4 ·
Receivables Turnover 8.1 ·
Per Saham 5
Data Per Saham Tahunan untuk MMED
Metrik Tren 20262025
Book Value / Share $12.86 ·
Revenue / Share $12.09 ·
Cash Flow / Share $-0.77 ·
Cash / Share $1.06 ·
EPS (TTM) $-1.30 ·
Tingkat Pertumbuhan 1
Data Tingkat Pertumbuhan Tahunan untuk MMED
Metrik Tren 20262025
Revenue YoY 2-point trend, +43.1% 14.2% 10.0%
Valuasi (TTM) 10
Data Valuasi (TTM) Tahunan untuk MMED
Metrik Tren 20262025
Revenue TTM $3.10B ·
Net Income TTM $-333M ·
Market Cap $3.71B ·
P/E -10.2 ·
P/S 1.2 ·
P/B 1.0 ·
P / Tangible Book 3.0 ·
P / Cash Flow -18.8 ·
P / FCF -8.8 ·
Earnings Yield -9.8% ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

Laporan Laba Rugi
2026-04-242025-04-252024-04-26
Pendapatan $3.10B$2.71B$2.47B
Margin Kotor % 54.2%——
Margin Operasi % -6.1%——
Laba Bersih $-333M$-213M$-112M
EPS Dilusian $-1.30$-0.84$-0.44
Neraca
2026-04-242025-04-252024-04-26
Rasio Lancar 1.9——
Rasio Cepat 0.7——
Arus Kas
2026-04-242025-04-252024-04-26
Arus Kas Bebas $-420M——

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

📊

Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

Orang dalam perusahaan 6 orang dalam · 3 pejabat · 0 direktur

Orang Dalam Peran Aktivitas terakhir Saham dimiliki Beli 12m Jual 12m Bersih 12m
Chad Spooner EVP, Chief Financial Officer 28 Juli 2026 F 362.707 0 0 $0
Gillian Chandrasena SVP, Chief HR Officer 28 Juli 2026 F 172.745 0 0 $0
John Gyurci VP, Chief Accounting Officer 1 Juli 2026 A 39.941 0 0 $0
Ali Dianaty — 31 Juli 2026 F 315.158 0 0 $0
Courtney Nelson Wills — 31 Juli 2026 F 136.384 0 0 $0
Que Dallara — 31 Juli 2026 F 884.749 0 0 $0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 7 ETF

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana Bobot Unit Per tanggal Sumber
IWN · iShares Trust 0,03% 265.996 SH 8 Agu 2026 Harian
VTWV · VANGUARD SCOTTSDALE FUNDS 0,03% 25.024 SH 8 Agu 2026 Harian
OMFS · Invesco Exchange-Traded Self-Indexe… 0,03% 3.717 SH 8 Agu 2026 Harian
IWM · iShares Trust 0,02% 737.097 SH 8 Agu 2026 Harian
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 165.581 SH 8 Agu 2026 Harian
VXF · VANGUARD INDEX FUNDS 0,00% 323.325 SH 8 Agu 2026 Harian
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 2.442 SH 8 Agu 2026 Harian